Abstract
The present review summarizes the available information on the effects of the three major classes of antianginal agents (nitrates, calcium and beta-blockers) on myocardial energy metabolism. It also discusses the role of some new molecules (L-carnitine trimetazidine and ranolazine) that have been proposed as an alternative pharmacological approach for the metabolic management of cardiac ischaemic syndromes.
| Original language | English |
|---|---|
| Pages (from-to) | 2-5 |
| Number of pages | 4 |
| Journal | European Heart Journal |
| Volume | 14 |
| Issue number | SUPPL. G |
| Publication status | Published - 1993 |
Fingerprint
Keywords
- Antianginal drugs
- Cardiac metabolism
- Ischaemic heart disease
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
Cite this
Chierchia, S. L., & Fragasso, G. (1993). Metabolic management of ischaemic heart disease. European Heart Journal, 14(SUPPL. G), 2-5.